20/20 Biolabs, Inc (AIDX) insider trading
Every open-market stock purchase and sale by 20/20 Biolabs, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent AIDX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 2, 2026 | Jiming Zhou (COO) | Bought (not open market) | — |
| Apr 2, 2026 | Alan B. Bergman (CFO) | Bought (not open market) | — |
| Mar 3, 2026 | Jonathan M Cohen (CEO) | Bought (not open market) | — |
| Feb 19, 2026 | John Woodson Rollins (Director) | Bought (not open market) | — |
| Feb 19, 2026 | Michael A. Ross (Director) | Bought (not open market) | — |
| Feb 19, 2026 | John G. Compton (Director) | Bought (not open market) | — |
| Feb 19, 2026 | John Woodson Rollins (Director) | Bought (not open market) | — |
| Feb 19, 2026 | Richard M Cohen (Director) | Bought (not open market) | — |
Who's trading AIDX
- Alan B. Bergman, CFO: other filings, last Apr 2, 2026
- Jiming Zhou, COO: other filings, last Apr 2, 2026
- Jonathan M Cohen, CEO: other filings, last Mar 3, 2026
- Michael A. Ross, Director: other filings, last Feb 19, 2026
- John G. Compton, Director: other filings, last Feb 19, 2026
- Richard M Cohen, Director: other filings, last Feb 19, 2026
- John Woodson Rollins, Director: other filings, last Feb 19, 2026
Get free alerts when an insider at 20/20 Biolabs, Inc files a new trade →